Diagnosis and treatment of disease caused by nontuberculous mycobacteria.
暂无分享,去创建一个
R. Wallace, | J. Glassroth | A. Dutt | R. O'Brien | J. Raleigh | R. Wallace
[1] R. Altman,et al. Chronic lymphadenopathy due to mycobacterial infection. Clinical features, diagnosis, histopathology, and management. , 1984, American journal of diseases of children.
[2] R. O'brien,et al. Usefulness of skin testing with mycobacterial antigens in children with cervical lymphadenopathy , 1992, The Pediatric infectious disease journal.
[3] J. Falkinham,et al. Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. , 1986, The Journal of infectious diseases.
[4] R. Wallace,,et al. Bacteremia caused by a previously unidentified species of rapidly growing Mycobacterium successfully treated with vancomycin. , 1983, Annals of internal medicine.
[5] C. Woodley,et al. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. , 1985, The Journal of infectious diseases.
[6] J. Musser,et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. , 1989, The Journal of infectious diseases.
[7] M. D. Del Beccaro,et al. Diagnostic usefulness of mycobacterial skin test antigens in childhood lymphadenitis. , 1989, The Pediatric infectious disease journal.
[8] R. Wallace,,et al. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid , 1991, Antimicrobial Agents and Chemotherapy.
[9] M. Luquin,et al. Mycobacterium xenopi infections in the acquired immunodeficiency syndrome. , 1988, Annals of internal medicine.
[10] L. Hoover,et al. Cervical mycobacterial lymphadenitis. Medical vs surgical management. , 1985, Archives of otolaryngology.
[11] R. Bolan,et al. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS , 1991, The Lancet.
[12] R. Kim. Tetracycline Therapy for Atypical Mycobacterial Granuloma , 1974 .
[13] G. Bodey,et al. Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. , 1987, The American journal of medicine.
[14] K J Ryan,et al. Antimicrobial Susceptibility Testing , 2016, Advances in Experimental Medicine and Biology.
[15] J. Steadham. High-catalase strains of Mycobacterium kansasii isolated from water in Texas , 1980, Journal of clinical microbiology.
[16] P. Jenkins,et al. Pulmonary infection with mycobacterium xenopi: review of treatment and response. , 1984, Thorax.
[17] R. Wallace,,et al. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. , 1983, Annals of internal medicine.
[18] M. Iseman,et al. Disseminated Infection with Mycobacterium avium‐intracellulare: A REPORT OF 13 CASES AND A REVIEW OF THE LITERATURE , 1985, Medicine.
[19] C. Collins,et al. Mycobacterium marinum infections in man , 1985, Journal of Hygiene.
[20] M. Rodriguez‐Barradas,et al. Disseminated Mycobacterium fortuitum disease in an AIDS patient. , 1992, The American journal of medicine.
[21] J. Grosset,et al. Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection. , 1988, Tubercle.
[22] A. A. Mel’nikova,et al. [Culture media for detection of antibiotic substances in actinomycetes]. , 1957, Mikrobiologiia.
[23] R. Wallace,,et al. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms , 1992, Antimicrobial Agents and Chemotherapy.
[24] Horsburgh Cr,et al. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). , 1989 .
[25] L. Heifets. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs , 1988, Antimicrobial Agents and Chemotherapy.
[26] D. Snider,et al. Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of mycobacterial diseases. , 1987, Reviews of Infectious Diseases.
[27] R. Schelonka,et al. Disseminated Mycobacterium avium complex in non-human immunodeficiency virus-infected pediatric patients. , 1992, The Pediatric infectious disease journal.
[28] P. Jenkins,et al. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. , 1987, Thorax.
[29] E. Wolinsky,et al. Mycobacteria in soil and their relation to disease-associated strains. , 2015, The American review of respiratory disease.
[30] M. Iseman,et al. Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. , 2015, The American review of respiratory disease.
[31] J. Hawkins,et al. Evaluation of a simple method for growing Mycobacterium haemophilum , 1985, Journal of clinical microbiology.
[32] M. Corrado,et al. Mycobacterium thermoresistibile: a new pathogen for humans , 1981, Journal of clinical microbiology.
[33] D. R. Deyoung,et al. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii , 1984, Antimicrobial Agents and Chemotherapy.
[34] G. Mccracken,et al. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. , 1979, The Journal of pediatrics.
[35] Wallace Rj. The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M. fortuitum and M. chelonae. , 1989 .
[36] V. Pryor,et al. Outbreak of Mycobacterium chelonae infection associated with use of jet injectors. , 1990, JAMA.
[37] S. Jay,et al. The course of untreated Mycobacterium kansasii disease. , 1975, The American review of respiratory disease.
[38] D. Armstrong,et al. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. , 1986, Annals of internal medicine.
[39] C. Smith,et al. A limited clinical, pathologic, and epidemiologic study of patients with pulmonary lesions associated with atypical acid-fast bacilli in the sputum. , 1957, American review of tuberculosis.
[40] F. Morinet,et al. Erythroid hypoplasia due to chronic infection with parvovirus B19. , 1990, The New England journal of medicine.
[41] A. Teirstein,et al. Solitary pulmonary nodules due to nontuberculous mycobacterial infection. , 1981, The American journal of medicine.
[42] C. Palmer,et al. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. , 1969, The American review of respiratory disease.
[43] A. Haemers,et al. Mycobacteria and the new quinolones , 1989, Antimicrobial Agents and Chemotherapy.
[44] D. Snider,et al. Isolation of nontuberculous mycobacteria in the United States, 1980. , 1982, The Journal of infectious diseases.
[45] C Thornsberry,et al. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae , 1985, Antimicrobial Agents and Chemotherapy.
[46] R. Good,et al. Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. , 1982, The Journal of infectious diseases.
[47] Nalin Rastogi,et al. Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents? , 1981, Antimicrobial Agents and Chemotherapy.
[48] R. Wallace,,et al. Human disease due to Mycobacterium smegmatis. , 1988, The Journal of infectious diseases.
[49] B. Parker,et al. Recent experience in the epidemiology of disease caused by atypical mycobacteria. , 1981, Reviews of infectious diseases.
[50] W. Johanson,et al. Mycobacterium simiae. Clinical features and follow-up of twenty-four patients. , 1983, The American review of respiratory disease.
[51] R. Corpe. Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare. , 1981, Reviews of infectious diseases.
[52] S. Eykyn,et al. The successful treatment of tropical fish tank granuloma (Mycobacterium marinum) with co‐trimoxazole , 1977, The British journal of dermatology.
[53] L. Christianson,et al. Pulmonary disease in adults associated with unclassified mycobacteria. , 1960, The American journal of medicine.
[54] A. Armstrong,et al. A clinical study of the chronic lung disease due to nonphotochromogenic acid-fast bacilli. , 1960, Annals of internal medicine.
[55] G. Meissner,et al. Sources of Mycobacterium avium complex infection resulting in human diseases. , 1977, The American review of respiratory disease.
[56] Grossman Wm,et al. Origin and significance of mycobacterium xenopi in clinical specimens. I. Water as a source of contamination. , 1976 .
[57] R. Good,et al. Spectrum of disease due to rapidly growing mycobacteria. , 1983, Reviews of infectious diseases.
[58] M. Iseman,et al. Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections. , 1991, The Annals of thoracic surgery.
[59] J. Raleigh,et al. Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin. , 1981, Reviews of infectious diseases.
[60] P. Davidson,et al. Treatment of disease due to Mycobacterium intracellulare. , 1981, Reviews of infectious diseases.
[61] E. H. Runyon,et al. The relationship of atypical acid-fast bacteria to human disease; a preliminary report. , 1954, The Journal of laboratory and clinical medicine.
[62] J. Simmank,et al. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex. , 1985, Diagnostic microbiology and infectious disease.
[63] C. Palmer,et al. Epidemiologic studies of tuberculin sensitivity. I. Preliminary results with purified protein derivatives prepared from atypical acid-fast organisms. , 1958, American journal of hygiene.
[64] N. D’Esopo,et al. Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. , 2015, The American review of respiratory disease.
[65] R. Selik,et al. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). , 1989, The American review of respiratory disease.
[66] R. Wallace,,et al. Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. , 1988, The New England journal of medicine.
[67] S. Siddiqi,et al. Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-alpha-acetylamino-beta-hydroxypropiophenone , 1984, Journal of clinical microbiology.
[68] P. Jenkins,et al. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. , 1983, Thorax.
[69] R. Good,et al. Nosocomial Mycobacterium fortuitum colonization from a contaminated ice machine. , 1988, The American review of respiratory disease.
[70] M. Iseman,et al. Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods , 1985, Antimicrobial Agents and Chemotherapy.
[71] George Tk,et al. Disseminated infection with Mycobacterium avium-intracellulare. , 1984 .
[72] J. McCutchan,et al. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group. , 1990, Annals of internal medicine.
[73] R. Wallace,,et al. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics , 1983, Antimicrobial Agents and Chemotherapy.
[74] R. Wallace,,et al. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. , 1981, Reviews of infectious diseases.
[75] G. L. White,et al. Atypical mycobacterial infection caused by Mycobacterium marinum. , 1990, The New England journal of medicine.
[76] J. McCormack,et al. Bacteremia caused by Mycobacterium neoaurum , 1988, Journal of clinical microbiology.
[77] C. Collins,et al. The isolation of M. kansasii and M. xenopi from water systems. , 1974, Tubercle.
[78] M. Ali,et al. Fine needle aspiration biopsy in the diagnosis of tuberculosis. , 1985, Acta cytologica.
[79] W. Baine,et al. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. , 1983, The Journal of infectious diseases.
[80] L. Bland,et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. , 1987, The New England journal of medicine.
[81] J. Kilburn,et al. High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species , 1986, Journal of clinical microbiology.
[82] D. Snider,et al. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. , 1987, The American review of respiratory disease.
[83] K. K. Lai,et al. Mycobacterial Cervical Lymphadenopathy: Relation of Etiologic Agents to Age , 1984 .
[84] M. Luquin,et al. In vitro activity of clofazimine against rapidly growing nonchromogenic mycobacteria , 1986, Antimicrobial Agents and Chemotherapy.
[85] Horsburgh Cr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.
[86] D. Murphy,et al. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex. , 2015, The American review of respiratory disease.
[87] L. Grayson,et al. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. , 1990, The Journal of infectious diseases.
[88] W. Sealy,et al. Long-term results of pulmonary resection for atypical mycobacterial disease. , 1983, The Annals of thoracic surgery.
[89] D. Peterson,et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. , 1989, The New England journal of medicine.
[90] S. Ahn,et al. Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs. , 1981, Reviews of infectious diseases.
[91] F. Kuze,et al. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. , 1981, Reviews of infectious diseases.
[92] C. Collins,et al. Thenatureofmycobacterial disease insoutheast England, 1977-84 , 1986 .
[93] R. Macgregor,et al. Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. , 1983, Reviews of infectious diseases.
[94] W. Stead,et al. Long-term results of medical treatment in Mycobacterium intracellulare infection. , 1979, The American journal of medicine.
[95] S. Ahn,et al. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. , 1983, The American review of respiratory disease.
[96] W. Schaffner,et al. Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant recipients. , 1989, The American journal of medicine.
[97] L. Heifets. Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare. , 2015, The American review of respiratory disease.
[98] W. Lester. Treatment of drug-resistant tuberculosis. , 1971, Disease-a-month : DM.
[99] R. Wallace,,et al. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. , 1985, The Journal of infectious diseases.
[100] P. Loria. Minocycline hydrochloride treatment for atypical acid-fast infection. , 1976, Archives of dermatology.
[101] F. Kocka,et al. Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome. , 1986, Annals of internal medicine.
[102] F. Robicsek,et al. Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex. , 1981, The Journal of infectious diseases.
[103] W. Bailey,et al. Surgical treatment of atypical mycobacterial lymphadenitis in children. , 1985, Pediatric infectious disease.
[104] D. Rimland,et al. Infections caused by Mycobacterium szulgai in humans. , 1987, Reviews of infectious diseases.
[105] A. Lavy,et al. Isolation of Mycobacterium simiae from clinical specimens in Israel. , 1982, Tubercle.
[106] W. Yew,et al. Combined use of fine-needle aspiration cytologic examination and tuberculin skin test in the diagnosis of cervical tuberculous lymphadenitis. A prospective study. , 1991, Archives of otolaryngology--head & neck surgery.
[107] E. Wolinsky. Nontuberculous mycobacteria and associated diseases. , 2015, The American review of respiratory disease.
[108] R. Wallace,,et al. Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii. , 2015, The American review of respiratory disease.
[109] P. Jenkins,et al. Pulmonary infection with Mycobacterium malmoense--a review of treatment and response. , 1985, Tubercle.
[110] C. Collins,et al. Mycobacteria in water. , 1984, The Journal of applied bacteriology.
[111] E. Lincoln,et al. Disease in children due to mycobacteria other than Mycobacterium tuberculosis. , 2015, The American review of respiratory disease.
[112] E. Baron,et al. Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome. , 1986, Diagnostic microbiology and infectious disease.
[113] B. Dautzenberg,et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. , 1991, The American review of respiratory disease.
[114] D. Dawson,et al. Investigation by seroagglutination of strains of the Mycobacterium intracellulare-M. scrofulaceum group from house dusts and sputum in Southeastern Queensland. , 1971, The American review of respiratory disease.
[115] R. Wallace,,et al. The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M. fortuitum and M. chelonae. , 1989, Clinics in chest medicine.
[116] R. Johnson,et al. Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting. , 1991, The American review of respiratory disease.
[117] R. W. James,et al. Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. , 1992, The Journal of pediatrics.
[118] Philip Smith,et al. Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampin. , 1986, Archives of internal medicine.
[119] R. Wallace,,et al. Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks , 1992, Journal of clinical microbiology.
[120] M. Iseman,et al. Determination of in vitro susceptibility of mycobacteria to ansamycin. , 2015, The American review of respiratory disease.
[121] R. Wallace,,et al. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. , 1992, The Journal of infectious diseases.
[122] S. P. Chow,et al. Mycobacterium marinum infection of the hand and wrist. Results of conservative treatment in twenty-four cases. , 1987, The Journal of bone and joint surgery. American volume.
[123] C. Woodley,et al. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. , 1982, The American review of respiratory disease.
[124] P M Southern,et al. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. , 1992, The Journal of infectious diseases.
[125] R. Johnson,et al. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. , 1992, Chest.
[126] M. Samadpour,et al. Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients , 1992, Journal of clinical microbiology.